NUFIP2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.529800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.042200E-01
Normal-vs-Stage2
9.975800E-01
Normal-vs-Stage3
1.147570E-01
Normal-vs-Stage4
2.380800E-01
Stage1-vs-Stage2
7.765800E-01
Stage1-vs-Stage3
2.656600E-03
Stage1-vs-Stage4
4.712200E-02
Stage2-vs-Stage3
7.075800E-02
Stage2-vs-Stage4
1.329580E-01
Stage3-vs-Stage4
3.836600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.238000E-01
Normal-vs-AfricanAmerican
8.387000E-01
Normal-vs-Asian
7.910600E-01
Caucasian-vs-AfricanAmerican
6.607800E-01
Caucasian-vs-Asian
7.430000E-01
AfricanAmerican-vs-Asian
5.286400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.629200E-01
Normal-vs-Female
9.566400E-01
Male-vs-Female
9.812000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.612000E-01
Normal-vs-Age(41-60Yrs)
6.234800E-01
Normal-vs-Age(61-80Yrs)
8.041800E-01
Normal-vs-Age(81-100Yrs)
2.771800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.555000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.438400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.437400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.340100E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.282330E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.409600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.540600E-01
Normal-vs-Daily Drinker
4.328200E-01
Normal-vs-Weekly Drinker
7.339800E-01
Normal-vs-Occasional Drinker
5.397000E-01
Normal-vs-Social Drinker
6.903600E-01
Non Drinker-vs-Daily Drinker
9.659600E-01
Non Drinker-vs-Weekly Drinker
4.700600E-01
Non Drinker-vs-Occasional Drinker
1.053610E-02
Non Drinker-vs-Social Drinker
1.477760E-02
Daily Drinker-vs-Weekly Drinker
5.216400E-01
Daily Drinker-vs-Occasional Drinker
1.036360E-02
Daily Drinker-vs-Social Drinker
3.544400E-02
Weekly Drinker-vs-Occasional Drinker
1.009570E-01
Weekly Drinker-vs-Social Drinker
2.165200E-01
Occasional Drinker-vs-Social Drinker
6.277800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.756000E-02
Normal-vs-Grade 2
4.519600E-03
Normal-vs-Grade 3
2.424200E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.047380E-01
Grade 1-vs-Grade 3
1.181750E-01
Grade 1-vs-Grade 4
3.756000E-02
Grade 2-vs-Grade 3
9.433000E-01
Grade 2-vs-Grade 4
4.519600E-03
Grade 3-vs-Grade 4
2.424200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.111800E-01
Normal-vs-NonDiabetic
9.944600E-01
Diabetic-vs-NonDiabetic
4.820000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.651000E-01
Normal-vs-NoPancreatitis
8.284600E-01
Pancreatitis-vs-NoPancreatitis
4.629800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.721200E-01
Normal-vs-N1
9.686600E-01
N0-vs-N1
3.024200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.768000E-01
Normal-vs-TP53-NonMutant
9.749800E-01
TP53-Mutant-vs-TP53-NonMutant
5.950200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
